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Background: Compliance with official recommendations can be assessed by evaluating vaccination coverage (VC)
in populations. The main objective of our study was to assess VC of adults against diphtheria, tetanus, poliomyelitis
and pertussis (dTPaP) according to age. The second objective was to explore if vaccination status could be
confirmed by documentation.
Methods: A cross-sectional study was conducted in 680 adults consulting for biological examination in private
laboratories in Lyon (France) to evaluate VC for diphtheria, tetanus, poliomyelitis and pertussis (dTPaP) and enabled
reported vaccinations to be compared with documented, confirmed vaccinations.
Results: Verification of documented, confirmed vaccinations disclosed VC of 78.7% for tetanus, 63.6% for
poliomyelitis, 57.8% for diphtheria and 10.7% for pertussis. Comparison of confirmed and self-reported vaccinations
revealed that a large percentage of people who thought that they were vaccinated were not. VC significantly
decreased with age for diphtheria and poliomyelitis and did not vary by gender. The VC rate for pertussis has
increased since the 2008 recommendations were made.
Conclusions: The main thrust of this study was to compare reported and confirmed data. A significant percentage
of people wrongly believed that they were up to date with their vaccination.
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Vaccination recommendations are updated in line with
changes in epidemiological data, the efficacy and tolerabil-
ity of existing vaccines, and the advent of new vaccines on
the market. Studies in France and Europe [1,2] have high-
lighted the need to improve vaccination policies. Ignor-
ance of the exact level of vaccination coverage (VC) in the
general population does not facilitate comparisons over
time or evaluation of vaccination impact. VC monitoring
of at-risk populations and within specific age groups
would be useful, aided by the establishment of indicators
in the general population for the main vaccination-
preventable diseases. Available sources of information are
personal child health records for young adults, new per-
sonal adult health records, university files, international* Correspondence: philippe.vanhems@chu-lyon.fr
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reproduction in any medium, provided the orvaccination records, occupational health records, medical
records, medical insurance companies and prescribing
physicians.
A sero-epidemiological investigation of adults reported
that the percentage of subjects with diphtheria and tet-
anus antibodies decreased with age and that 7.6% of the
population studied (13.4% of those aged 18–29 years)
had recently been infected by pertussis [3]. These results
underline the need for better application of the recom-
mendations for pertussis booster vaccines in adults [4].
The lack of any systematic follow-up of VC and the het-
erogeneous nature of various practices [5] might partly
explain such observations. The population’s perception
of vaccination is also a determining factor, and indivi-
duals’ knowledge of their vaccination status is probably
not optimal.
The primary objective of our study was to evaluate
adult diphtheria, tetanus, polio and pertussis (dTPaP)
VC by age in the general population. The secondary
objectives were to compare self-reported dTPaP VC withLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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to verify dTPaP vaccination in adults.Methods
Study setting and data collection
Our cross-sectional study was conducted in co-
operation with 6 private medical analysis laboratories
located in different districts of Lyon, a city with more
than 480,000 inhabitants. Each laboratory covered about
14,000 inhabitants. Laboratory participation was volun-
tary and previously effective in collaborative academic
epidemiological studies [5].
Subjects included in the survey were aged over 19
years and had to have attended a medical analysis la-
boratory for tests of any kind (glycaemia, serology,
etc.). All patients were contacted but only those volun-
teering to participate were enrolled. After informing
each study subject and obtaining signed consent,
research assistants collected vaccination data with a
standardised questionnaire complemented by socio-
demographic data. Vaccination documentation was al-
ways requested. Data on subjects’ knowledge of their
vaccination status focused on diphtheria, tetanus,
poliomyelitis, pertussis, and the conditions under
which these vaccinations were given. Questions were
asked in relation to pertussis: intention to become par-
ents, pregnancy, contact with children under 6 months
old and knowledge of the disease. Vaccination data
were validated by documentary “evidence” of vaccin-
ation. Descriptive analysis was performed relative to
socio-demographic factors and vaccination data sup-
ported by documentary “evidence”. Subjects vaccinated
within the past 10 years were considered to be up to
date with their vaccination according to the 2011
French adult immunization schedule (Table 1).
Our survey was conducted from October 13, 2010 to
February 11, 2011, after approval by the Advisory Com-
mittee on Data Processing in Medical Research and the
French National Data Protection Committee.Table 1 2011 French immunisation schedule – Recommendat
General
recommendations








Catch-up program Acellular pertussis (aP)
Specific and at-risk
populations
Acellular pertussis (aP) A single dose of dTaP-IPV in ad
during pregnancy and post-par
and dTaP-IPVStatistical analysis
Qualitative variables were reported as number and per-
centage, and quantitative variables, as means and standard
deviation. VC was calculated for 100 subjects with 95%
confidence interval (95% CI). Categorical variables
were compared by the Chi square test or Fisher’s exact
test as appropriate (less than 5 individuals by cell in
2X2 tables). All data were analysed anonymously with
SPSS 17.0 software for Windows (SPSS Statistics Inc.,
Chicago, IL, USA).Results
Study population characteristics
A total of 680 subjects, aged over 19 years, were surveyed
among all patients who attended 6 laboratories during the
study period. Median age was 60 years (min: 20, max: 91),
and the gender ratio (M/F) was 0.68. Pensioners (56.9%)
were the most commonly-represented occupational group,
followed by business executive and managers (11.6%), the
unemployed, disabled or students (8.0%), healthcare pro-
fessionals (9.3%), labourers (3.1%), artisans-shopkeepers-
business people (0.9%) and farmers (0.4%). Master’s degree
(20.6%) was the most frequently-found educational level.
Healthcare professionals who administered vaccinations
were, in the great majority of cases, family physicians
(77%), vaccination centres (9.6%), occupational physicians
(8.8%), hospital centres and nurses (0.8%).
In the specific case of pertussis, 15.6% of subjects
intended to become parents shortly after the survey,
8.2% were pregnant (or their partner was), and 19.1%
had frequent contact with children under 6 months of
age. On interview, a third of people who intended to
become parents, a third of pregnant women (or their
partners) and a third of people in contact with children
under 6 months of age thought about getting vacci-
nated against pertussis. Twenty-nine percent were
aware of the value of pertussis vaccination, and 21%
of them knew how serious pertussis infection was
in adults.ions for adults
8 years 30-45 years 46-64 years ≥65 years
V to be replaced by a single
of dTaP-IPV for adults who
not received pertussis
ination since 10 years
1 dose of dT-IPV every 10 years
Replaced by a single dose of dTaP-IPV
for adults who have not previously
received pertussis vaccination
ults with the prospect of becoming parents (cocoon), family members
tum women (minimum interval of 2 years between 1 dose of dT-IPV
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reported having vaccination documentation. This docu-
mentary evidence assumed different forms: vaccination
record (52.9%), vaccination card or certificate (34.2%),
and personal health record (12.9%). Table 2 describes
the characteristics of study subjects and the Lyon city
population.Table 2 Characteristics of individuals with documentation










Median [IQR**] 63 [51–73] 40 [28–58]
Strata
20-40 15.1 % 47%
41-60 27.1% 28%
61-80 46.7 % 17%
>80 11.1 % 6%
Sex
Male 35.6 % 46%




Business executive or managers 11.6% 16.9%
Unemployed, student or disabled 8.0% 21.1%
Healthcare professionals 9.3% 17.4%
Labourers 3.7% 7.6%
Artisans, shopkeepers, business people 0.9% 2.5%
Farmers 0.4% 0.0%
Educational level
Master’s degree level 2 (Bachelor + ≥3) 30.2% 28.4%
Master’s degree level 1 (Bachelor + 2) 12.4% 15.9%
Bachelor 20.9% 15.9%
GCSE***, Certificate in vocational training,
Technical School Certificate
20.9% 18.9%
Basic school-leaving qualification 12.0% 6.8%







* data from the french national agency for demographic data (www.insee.fr).
** InterQuartile range *** General Certificate of Secondary Education.Concerning self-reported vaccination, those who pro-
duced documentation, as opposed to those who did
not, were predominantly women (64.4% vs 56.7%,
p=0.05), older people (mean age: 60.7 vs 55.5 years,
p=0.001) and people who thought they were up to date
with their vaccinations apart from pertussis vaccination
(Table 3).
Vaccine coverage by age
Verification of vaccinations confirmed by documentary
evidence (n=225) showed VC of 57.8% for diphtheria,
78.7% for tetanus, 63.6% for poliomyelitis and 10.7% for
pertussis (Table 4). VC for each of the 4 valences studied
did not vary with gender. VC for diphtheria and poliomy-
elitis, but not for tetanus or pertussis, decreased signifi-
cantly with age (Table 4). For confirmed vaccinations, 128
people received combined dT-IPV vaccination (vaccines
injected on the same day and in a single dose: dT-IPV
and dTaP-IPV are the most commonlyadministered vac-
cines in France). VC with combined vaccination did not
differ significantly with gender, but decreased with age.
Some people received a single valence (tetanus), for which
a VC gradient with age was observed (Table 4).
Since the publication of pertussis recommendations in
March 2008, VC rates appear to have increased (data
not reported) but no pregnant women (0/11) in our
study were up to date with their pertussis vaccination.
No significant difference for pertussis vaccination
appeared between men and women (p: 0.50). Moreover,
4% (1/26) of subjects intending to become parents were
vaccinated, and 16% (6/36) of those in contact with
infants under 6 months of age were vaccinated.
Vaccine status according to documentation reported
or not
Subjects who thought the most that they were up to date
with vaccination, compared to those were not, provided
documentation (81%/60%, p<0.001). In total, people with
documentation believed that they were up to date with
their vaccinations, 70.2% for diphtheria, 95.6% for tet-
anus, 76.0% for poliomyelitis, and 22.2% for pertussis.
Comparison of confirmed and reported vaccinations by
subject revealed that some who thought they were vacci-
nated for diphtheria; tetanus; poliomyelitis and pertussis
were actually not (Table 5). Conversely, some subjects
who thought they were not vaccinated were up to date
with their vaccinations.
Discussion
The VC rates obtained were similar to those observed in
national and regional evaluations [6-8]. These authors
analysed the methods and tools employed in France to
ascertain vaccination coverage in adults and concluded
that it was difficult to collect information on VC in adult
Table 3 Self-reported vaccination of Lyon city subjects producing documentation or not, October 2010-February 2011







Female 258 (56.7) 145 (64.4) <10-3 403 (59.3)
Male 197 (43.3) 80 (35.6) 277 (40.7)
Age (years)
Mean (±SD) 55.5 (± 19.1) 60.7 (± 16.1) 0.001 57.2 [± 18.3]
Median [min-max] 57 [20–91] 63 [21–87] - 60 [20–91]
Age strata
20-40 123 (27.0) 34 (15.1) 0.02 157 (23.1)
41-60 129 (28.4) 61 (27.1) 190 (27.9)
61-80 159 (34.9) 105 (46.7) 264 (38.8)
>80 44 (9.7) 25 (11.1) 69 (10.1)
Subjects reporting being up to date with
their vaccinations n (%) [95% CI of %]
274 (60.2) [55.9-68.7] 183 (81.3) [75.8-86.0] <10-3 457 (67.2) [63.3-70.7]
Subjects reporting being up to date with each vaccination n (%) [95% CI of %]
Diphtheria 293 (64.4) [59.9-68.7] 158 (70.2) [64.0-75.9] 0.002 51 (66.3) [62.7-69.8]
Tetanus 383 (84.4) [80.6-87.3] 215 (95.6) [92.9-97.7] <10-3 599 (88.1) [85.5-90.4]
Poliomyelitis 306 (67.3) [62.8-71.4] 171 (76.0) [61.1-72.6] 0.001 477 (70.1) [66.6-73.5]
Pertussis 105 (23.1) [19.4-27.1] 50 (22.2) [15.1-24.8] 0.96 155 (22.8) [19.8- 26.1]
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assessing VC is serological testing, but it is very expen-
sive and not easy to implement in population surveys.
The geographical and social diversity of participating
laboratories ironed out any existing disparities. A re-
cruitment bias could not be totally excluded, and recall
bias was difficult to avoid. However, the likelihood that
vaccination status was related to prescribed laboratory
tests was very low and, in this case, selection bias would
be limited. Care should be taken when generalising the
results because the participating laboratories were not
randomised.
The population interviewed was relatively elderly,
retired and therefore more inclined to provide documen-
tation by virtue of its greater availability. The population
group likely to be parents (20–40 years) and reporting
documentation (15.1%) was under-represented com-
pared to that observed in Lyon city (47%). In addition,
pertussis vaccination is not recommended during preg-
nancy in France, which does not allow us to compare
the data to other countries.
Subjects agreeing to participate in the survey and to
produce vaccination documentation might be more in
tune with their health and more aware of the need to re-
main up to date with their vaccinations. A similar survey
compared reported vaccinations with vaccinations con-
firmed by documentary evidence [9].These findings might not be generalizable to the
French population but may be representative of popula-
tions in large French cities (i.e. Paris, Marseille, and
Strasbourg) or other large European cities.
dT-IPV VC decreases with age and requires the institu-
tion of vaccination campaigns among older people,
underlining the importance of administering tetanus vac-
cine combined with other valences in accordance with
official recommendations. Data collection tools for vac-
cination coverage appear to be incomplete and imprecise.
Targeted surveillance to detect regional and social differ-
ences would be desirable [10].
Conclusions
VC measurement should be a public health priority to
improve health education campaigns. Our study under-
lined the need to highlight prevention messages relating
to vaccination. Its main value was documentary evi-
dence. Comparison of reported data with confirmed data
revealed a considerable percentage of subjects who
wrongly believed their vaccinations to be up to date, par-
ticularly for pertussis. The percentage of people who
thought they were vaccinated but who were not should
prompt health authorities to develop VC monitoring
programmes to prevent insufficient vaccination due to
ignorance of individual status. The collection of vaccin-
ation coverage data needs to be improved and could be




n (Yes %) [95% CI of %]
Vaccinated subjects
n (Yes %) [95% CI of %]
p*
Diphtheria 92 (42.2) [35.9-48.7] 130 (57.8) [51.2-64.1] 0.001
20-40 years 34 9 (26.5) [13.8-43.1] 25 (73.5) [56.9-86.3]
41-60 years 61 21 (34.4) [23.3-46.9] 40 (65.6) [53.0-76.7]
61-80 years 105 49 (46.7) [37.3-56.2] 56 (53.3) [43.7-62.7]
>80 years 25 16 (64.0) [44.1-80.8] 9 (36.0) [19.2-57.5]
Tetanus 48 (21.3) [16.4-27.1] 177 (78.7) [72.9-83.9] 0.83
20-40 years 34 9 (26.5) [13.8-43.1] 25 (73.5) [56.9-86.3]
41-60 years 61 14 (23.0) [13.7-34.7] 47 (77.0) [65.3-86.3]
61-80 years 105 14 (13.3) [7.8-20.8] 91 (86.7) [79.1-92.2]
>80 years 25 11 (44.0) [25.7-63.6] 14 (56.0) [36.4-74.3]
Polio 82 (36.4) [30.4-42.9] 143 (63.6) [57.1-69.7] 0.005
20-40 years 34 9 (26.5) [12.9-44.4] 25 (73.5) [55.6-87.1]
41-60 years 61 18 (29.5) [18.5-42.6] 43 (70.5) [57.4-81.5]
61-80 years 105 39 (37.1) [27.9-47.1] 66 (62.9) [52.9-72.1]
>80 years 25 16 (64.0) [42.5-83.0] 9 (36.0) [17.9-57.5]
Pertussis 201 (89.3) [84.8-92.9] 24 (10.7) [7.1-15.2] 0.34
20-40 years 34 30 (88.2) [72.6-96.7] 4 (11.8) [3.3-27.5]
41-60 years 61 54 (88.5) [77.8-95.3] 7 (11.5) [4.7-22.2]
61-80 years 105 92 (87.6) [79.7-93.3] 13 (12.4) [6.7-20.3]
>80 years 25 25 (100) 0 (0)
dT-IPV ** 97 (43.1) [36.8-49.7] 128 (56.91) [50.4-63.3] 0.01
20-40 years 34 9 (26.5) [13.8-43.1] 25 (73.5) [56.9-86.3]
41-60 years 61 21 (34.4) [23.3-46.9] 40 (65.6) [53.0-76.7]
61-80 years 105 51 (48.6) [39.1-58.1] 54 (51.4) [41.9-60.9]
>80 years 25 16 (64.0) [44.1-80.8] 9 (36) [19.2-57.5]
Tetanus alone 187 (83.2) [77.8-87.8] 38 (16.8) [12.4-22.2 ] 0.01
20-40 years 34 34 (100.0) 0 (0)
41-60 years 61 56 (91.8) [82.8-96.3] 5 (8.2) [2.7-18.1]
61-80 years 105 77 (73.3) [64.3-81.1] 28 (26.7) [18.9-35.7]
>80 years 25 20 (80.0) [61.1-92.3] 5 (20) [6.8-40.7]
*Statistical difference between those who were vaccinated and those who were not.
**Diphtheria, tetanus and poliomyelitis combined.
Table 5 Reported vaccinations (RV) versus confirmed
vaccinations (CV), Lyon city, October 2010-February 2011
Subjects reporting
documentation n=225
RV n CV n RV-CV/CV*
Yes% [95% CI of %]
Diphtheria 158 100 36.7% [29.5-44.4]
Tetanus 215 171 20.5% [15.5-26.3]
Poliomyelitis 171 119 30.4% [23.9-36.6]
Pertussis 50 9 82.0% [69.5-90.5]
* % of people who thought that they were up to date and were not.
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place. Investigations should evaluate the characteristics
of individuals who incorrectly report their vaccine status.
This issue was not explored because of limited sample
size. Improving vaccination coverage involves adapting
measurement tools, developing public information cam-
paigns, training doctors and ensuring a better under-
standing on the part of the general public.Competing interests
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